Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Treatment for extreme drug-resistant tuberculosis wins US government approval

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


Updates & Corrections

  • Update 15 August 2019: This story has been updated with comment from Mel Spigelman, president of the TB Alliance, and Sharonann Lynch, TB policy advisor for Médecins Sans Frontières (also known as Doctors Without Borders).


  1. Shah, N.S. et al. N. Engl. J. Med. 376, 243-253 (2017).

    Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links